[Should benefit-risk ratio of the intramuscular vitamin K be reevaluated in newborn infants?]. [electronic resource]
- Archives de pediatrie : organe officiel de la Societe francaise de pediatrie May 1996
- 415-8 p. digital
Publication Type: Editorial; Review
0929-693X
10.1016/0929-693x(96)86397-4 doi
Age Factors Humans Infant, Newborn Injections, Intramuscular Neoplasms--chemically induced Odds Ratio Risk Assessment Vitamin K--administration & dosage Vitamin K Deficiency Bleeding--chemically induced